
- Volume 0 0
RISING MEDICAID COSTS PEGGED TO ANTIDEPRESSANT Rxs
A sharp increase in prescriptions forpricey antidepressant drugs is driving upthe cost of the Medicaid drug program atan alarming rate, said researchers at theAgency for Healthcare Research andQuality.
In the 5 years from 1997 to 2002, thecost of Medicaid drugs more than doubledfrom $11.6 billion to $23.7 billion.Overall spending on Medicaid outpatientdrugs increased by 20% a year, theresearchers reported. A key factor in thatincrease is that the number of Medicaidbeneficiaries taking antidepressantsclimbed by 50% during the course of the5-year study, while spending for thesemedications shot up by 130%.
The investigators also found thatincreasing rates of prescribing forcyclooxygenase-2 inhibitors, protonpump inhibitors, and cholesterol-loweringmedications are driving up Medicaidcosts.
Articles in this issue
over 19 years ago
Hypertensionover 19 years ago
rx PRODUCTsover 19 years ago
OTC Productsover 19 years ago
health-systems PRODUCT newsover 19 years ago
can you READ these Rxs?over 19 years ago
Recognizing and Preventing a Heart Attackover 19 years ago
compounding HOTLINEover 19 years ago
The Role of Gastroprotection in Patients on NSAID Therapyover 19 years ago
Compounded Treatments for Migrainesover 19 years ago
Dealing with a Suspected Forgery Goes off TrackNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.














































































































































































































